Brief: Context Therapeutics Reports First Quarter 2023 Operating And Financial Results
10/05/2023 23:29
May 10 (Reuters) - Context Therapeutics Inc CNTX.O :
* CONTEXT THERAPEUTICS REPORTS FIRST QUARTER 2023 OPERATING
AND
FINANCIAL RESULTS
* CONTEXT THERAPEUTICS - CASH AND CASH EQUIVALENTS OF $29.8
MILLION AS OF MARCH 31, 2023
* CONTEXT THERAPEUTICS - CTIM-76 IND FILING ON TRACK FOR Q1
2024
* CONTEXT THERAPEUTICS - QTRLY LOSS PER SHARE $0.40
Source text for Eikon: ID:nGNX7Qqfrt
Further company coverage: CNTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Context Therapeutics
See all newsContext Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Context Therapeutics Q2 net loss widens on higher R&D costs
Context Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Context Therapeutics Announces Positive Interim Efficacy And Safety Results From Ongoing Phase 1 Clinical Trial For CTIM-76
Brief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202